Acceptability and Appropriateness of Information Sessions to Increase Knowledge and Awareness of PrEP and TelePrEP Among Latina Women

Overview

Journal AIDS Care

Publisher Informa Healthcare

Specialty Infectious Diseases

Date 2024 Jun 29

PMID 38943675

Authors

Dilara K Uskup

Omar Nieto

Elena Rosenberg-Carlson

Ronald A Brooks

Affiliations

Soon will be listed here.

Abstract

Women of color are disproportionately impacted by HIV. Although PrEP effectively prevents HIV infection, PrEP coverage and knowledge remain low in this population. To address barriers to PrEP, we implemented women-centered and culturally appropriate Information Sessions (IS) delivered by staff from the population they serve to increase knowledge, awareness, and use of PrEP through telemedicine (e.g., PlushCare). Our analysis focuses on Latina women (LW) participants, given the dearth of literature dedicated to the needs of LW. We partnered with a woman-led community-based organization (CBO) to implement the strategy with LW clients. Health educators conducted 26 IS with 94 LW (20 in Spanish and 6 in English). Participants who completed the IS were invited for interviews to assess the acceptability and appropriateness of the IS to increase knowledge and awareness of PrEP and PlushCare. Four themes emerged from the thematic analysis: (1) IS increased knowledge and awareness of PrEP and PlushCare; (2) perceived acceptability and appropriateness of IS; (3) insufficient reasons to warrant use of PrEP; and (4) positive attitudes about PlushCare. Our findings suggest that a women-centered and culturally appropriate IS implemented through a trusted, woman-led CBO is an acceptable and appropriate implementation strategy to inform LW about PrEP.

References

Thigpen M, Kebaabetswe P, Paxton L, Smith D, Rose C, Segolodi T . Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012; 367(5):423-34. DOI: 10.1056/NEJMoa1110711. View

Willie T, Kershaw T, Campbell J, Alexander K . Intimate Partner Violence and PrEP Acceptability Among Low-Income, Young Black Women: Exploring the Mediating Role of Reproductive Coercion. AIDS Behav. 2017; 21(8):2261-2269. PMC: 5823269. DOI: 10.1007/s10461-017-1767-9. View

Baugher A, Trujillo L, Kanny D, Freeman J, Hickey T, Sionean C . Racial, Ethnic, and Gender Disparities in Awareness of Preexposure Prophylaxis Among HIV-Negative Heterosexually Active Adults at Increased Risk for HIV Infection - 23 Urban Areas, United States, 2019. MMWR Morb Mortal Wkly Rep. 2021; 70(47):1635-1639. PMC: 8612510. DOI: 10.15585/mmwr.mm7047a3. View

Calabrese S, Dovidio J, Tekeste M, Taggart T, Galvao R, Safon C . HIV Pre-Exposure Prophylaxis Stigma as a Multidimensional Barrier to Uptake Among Women Who Attend Planned Parenthood. J Acquir Immune Defic Syndr. 2018; 79(1):46-53. PMC: 6092222. DOI: 10.1097/QAI.0000000000001762. View

Hojilla J, Koester K, Cohen S, Buchbinder S, Ladzekpo D, Matheson T . Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes. AIDS Behav. 2015; 20(7):1461-9. PMC: 4592687. DOI: 10.1007/s10461-015-1055-5. View

Siegler A, Mouhanna F, Mera Giler R, Weiss K, Pembleton E, Guest J . The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018; 28(12):841-849. PMC: 6286209. DOI: 10.1016/j.annepidem.2018.06.005. View

Teitelman A, Tieu H, Flores D, Bannon J, Brawner B, Davis A . Individual, social and structural factors influencing PrEP uptake among cisgender women: a theory-informed elicitation study. AIDS Care. 2021; 34(3):273-283. PMC: 8426410. DOI: 10.1080/09540121.2021.1894319. View

Felsher M, Szep Z, Krakower D, Martinez-Donate A, Tran N, Roth A . "I Don't Need PrEP Right Now": A Qualitative Exploration of the Barriers to PrEP Care Engagement Through the Application of the Health Belief Model. AIDS Educ Prev. 2018; 30(5):369-381. PMC: 8558876. DOI: 10.1521/aeap.2018.30.5.369. View

Collier K, Colarossi L, Sanders K . Raising Awareness of Pre-Exposure Prophylaxis (PrEP) among Women in New York City: Community and Provider Perspectives. J Health Commun. 2017; 22(3):183-189. DOI: 10.1080/10810730.2016.1261969. View

10.

Auerbach J, Kinsky S, Brown G, Charles V . Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care STDS. 2014; 29(2):102-10. PMC: 4321978. DOI: 10.1089/apc.2014.0142. View

11.

Chittamuru D, Frye V, Koblin B, Brawner B, Tieu H, Davis A . PrEP Stigma, HIV Stigma, and Intention to Use PrEP among Women in New York City and Philadelphia. Stigma Health. 2020; 5(2):240-246. PMC: 7654828. DOI: 10.1037/sah0000194. View

12.

Bradley E, Hoover K . Improving HIV Preexposure Prophylaxis Implementation for Women: Summary of Key Findings From a Discussion Series with Women's HIV Prevention Experts. Womens Health Issues. 2018; 29(1):3-7. DOI: 10.1016/j.whi.2018.08.004. View

13.

Razon N, Rodriguez A, Carlson K, Witt J, Logan R, Chambers B . "Far More than Just a Prescription": Focus Groups With U.S. Family Planning Providers and Staff About Integrating PrEP for HIV Prevention Into Their Work. Womens Health Issues. 2021; 31(3):294-300. PMC: 10191632. DOI: 10.1016/j.whi.2021.02.006. View

14.

Wong K, Stafylis C, Klausner J . Telemedicine: a solution to disparities in human immunodeficiency virus prevention and pre-exposure prophylaxis uptake, and a framework to scalability and equity. Mhealth. 2020; 6:21. PMC: 7138949. DOI: 10.21037/mhealth.2019.12.06. View

15.

Walters S, Platt J, Anakaraonye A, Golub S, Cunningham C, Norton B . Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention. AIDS Behav. 2021; 25(12):3987-3999. PMC: 8210500. DOI: 10.1007/s10461-021-03353-2. View

16.

Sun C, Anderson K, Kuhn T, Mayer L, Klein C . A Sexual Health Promotion App for Transgender Women (Trans Women Connected): Development and Usability Study. JMIR Mhealth Uhealth. 2020; 8(5):e15888. PMC: 7251477. DOI: 10.2196/15888. View

17.

Baldwin A, Light B, Allison W . Pre-Exposure Prophylaxis (PrEP) for HIV Infection in Cisgender and Transgender Women in the U.S.: A Narrative Review of the Literature. Arch Sex Behav. 2021; 50(4):1713-1728. PMC: 8213571. DOI: 10.1007/s10508-020-01903-8. View

18.

Jackson G, Darlington C, Tieu H, Brawner B, Flores D, Bannon J . Women's views on communication with health care providers about pre-exposure prophylaxis (PrEP) for HIV prevention. Cult Health Sex. 2021; 24(5):642-656. PMC: 8567214. DOI: 10.1080/13691058.2021.1877824. View

19.

Goparaju L, Experton L, Praschan N, Warren-Jeanpiere L, Young M, Kassaye S . Women want Pre-Exposure Prophylaxis but are Advised Against it by Their HIV-positive Counterparts. J AIDS Clin Res. 2016; 6(11):1-10. PMC: 4807623. DOI: 10.4172/2155-6113.1000522. View

20.

Hirschhorn L, Brown R, Friedman E, Greene G, Bender A, Christeller C . Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago. J Acquir Immune Defic Syndr. 2020; 84(5):497-507. PMC: 7378883. DOI: 10.1097/QAI.0000000000002377. View